Prevalence, awareness, treatment and control of hypertension in elderly Chinese

Hypertension Research

Volumn 36, Issue 9, 2013, Pages 824-828

  Sheng, Chang Sheng ^a   Liu, Ming ^a   Kang, Yuan Yuan ^a   Wei, Fang Fei ^a   Zhang, Lu ^a   Li, Ge Le ^a   Dong, Qian ^a   Huang, Qi Fang ^a   Li, Yan ^a   Wang, Ji Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

awareness; elderly Chinese; prevalence; treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS RESERPINE; RESERPINE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; BODY MASS; CHINESE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; OSCILLOMETRY; PREVALENCE; SITTING; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; AWARENESS; BLOOD PRESSURE; CHINA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES;

EID: 84883854007     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.57     Document Type: Article

References (20)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275: 1571-1576. (Pubitemid 26154243)
2. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361: 1629-1641. (Pubitemid 36579003)
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223. (Pubitemid 40138015)
4. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007; 55: 1056-1065. (Pubitemid 47024610)
5. Kannel WB. Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens 2000; 13: S3-S10.
6. Segura J, Ruilope LM, Zanchetti A. On the importance of estimating renal function for cardiovascular risk assessment. J Hypertens 2004; 22: 1635-1639. (Pubitemid 39141949)
7. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287: 1003-1010. (Pubitemid 34252058)
8. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, Ma GS, Yang XG. Technical Working Group of China National Nutrition and Health Survey. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol 2005; 26: 478-484. in Chinese.
9. Hu SS, Kong LZ, Gao RL, Zhu ML, Wang W, Wang YJ, Wu ZS, Chen WW, Liu MB. Editorial Board. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci 2012; 25: 251-256.
10. He L, Tang X, Song Y, Li N, Li J, Zhang Z, Liu J, Yu L, Xu H, Zhang J, Hu Y. Prevalence of cardiovascular disease and risk factors in a rural district of Beijing, China: a population-based survey of 58,308 residents. BMC Public Health 2012; 12: 34.
11. Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, Gu D, Feigin V, Jamrozik K, Ohkubo T, Woodward M. Asia-Pacific Cohort Studies Collaboration. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens 2007; 25: 73-79. (Pubitemid 44885666)
12. McFadden CB, Brensinger CM, Berlin JA, Townsend RR. Systematic review of the effect of daily alcohol intake on blood pressure. Am J Hypertens 2005; 18: 276-286. (Pubitemid 40332559)
13. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998; 68: 899-917.
14. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49: 69-75. (Pubitemid 46360343)
15. Committee for Revision of Chinese Guidelines for Prevention and Treatment of Patients with Hypertension. Chinese guidelines for prevention and treatment of patients with hypertension. Chin J Hypertens 2005; 134: 2-41 [in Chinese].
16. Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39: 579-615 [in Chinese].
17. Li Y, Wang JG, Gao PJ, Wang GL, Qian YS, Zhu DL, Staessen JA. Interaction between alcohol intake and body mass index in relation to blood pressure in HAN and SHE Chinese. Am J Hypertens 2006; 19: 448-453.
18. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-1686. (Pubitemid 33124327)
19. Mattila R, Malmivaara A, Kastarinen M, Kivelä SL, Nissinen A. Effectiveness of multidisciplinary lifestyle intervention for hypertension: a randomised controlled trial. J Hum Hypertens 2003; 17: 199-205. (Pubitemid 36388804)
20. Gupta AK, Nasothimiou EG, Chang CL, Sever PS, Dahlöf B, Poulter NR. ASCOT investigators. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk. J Hypertens 2011; 29: 2004-2013.